Browse the evidence

Integrating shared decision-making (SDM) into obesity management enhances patient-centered care and has the potential to improve long-term outcomes.

Practitioners should consider incorporating SDM to enhance patient engagement and outcomes in obesity care.

Programs incorporating SDM reported improved patient engagement, satisfaction, and health outcomes across diverse demographic groups.

Incorporating SDM can lead to better patient experiences and outcomes in obesity management.

Common facilitators of SDM success include the use of decision aids, culturally tailored counseling, and multidisciplinary team involvement.

Healthcare providers should utilize decision aids and culturally tailored approaches to enhance SDM in obesity care.

Long-term intake of UPFs leads to addiction due to additives including fat, caffeine, and sugar.

Health professionals should consider the addictive potential of UPFs when advising clients.

Significant improvements were observed across quality-of-life scores.

Incorporating exercise and nutrition can enhance the quality of life for breast cancer patients.

Total daily calorie intake measured by the questionnaire correlated with formal dietary review.

The questionnaire can provide a reliable estimate of calorie intake for dietary assessments.

85.6% of patients documented red flag dietary behaviors.

Clinicians should be aware of the high prevalence of concerning dietary behaviors in GI patients.

Distant teams lost similar amounts of weight in all 3 arms but did not keep it off during maintenance.

Interventions may need to address long-term maintenance strategies for participants like Distant teams.

Delaying breakfast from 0700 h to 0930 h or 1200 h reduces postprandial glycaemia.

Practitioners can recommend delaying breakfast to improve glycaemic control in patients with type 2 diabetes.

Non-genetic factors are involved in determining body weight and body composition.

Practitioners should consider non-genetic factors when addressing body weight and composition.

Human eating behavior is a learned habitual behavior influenced by past experiences.

Understanding that eating habits are learned can help practitioners develop better interventions.

The metabolic phenotype can be modified and affects the fate of ingested energy.

Practitioners should recognize that metabolic adaptations can influence weight management strategies.

Controlling the activities of inflammatory mediators can reduce the incidence of chronic diseases.

Diet, exercise, and lifestyle choices should focus on managing inflammation.

Human obesity is associated with insulin resistance and results in metabolic abnormalities and cardiovascular complications.

Practitioners should be aware of the metabolic and cardiovascular risks associated with obesity.

Associations between obesity and health are likely causal.

Understanding that obesity has likely causal links to health can guide interventions.

Incretin mimetics have a positive impact on related comorbidities, such as sleep apnea and heart failure.

Practitioners should be aware of the broader health benefits of incretin mimetics beyond glucose control.

Patients may benefit from education on proper drug administration, anticipated adverse effects, and nutrition considerations with treatment.

Educating patients on these aspects can improve treatment adherence and outcomes.

Durable LVAD patients treated with GLP-1 RA had a significant weight reduction from 116 kg to 110 kg (p-value < 0.001).

GLP-1 RA may be effective for weight management in LVAD patients.

GLP-1 RA therapy improved HBA1C levels from 6.4 to 5.7 (p-value 0.003) in LVAD patients.

GLP-1 RA may help improve glycemic control in LVAD patients.

White rice intake is associated with a 18% increased risk of type 2 diabetes mellitus (T2DM) when comparing the highest with the lowest category of intake.

Practitioners should consider the potential increased risk of T2DM when advising on white rice consumption.

Every additional 150 grams of white rice intake per day is associated with a 6% greater risk of T2DM.

Increasing white rice intake may elevate T2DM risk, which should be considered in dietary recommendations.

Dulaglutide showed consistent reductions in HbA1c (1.1%) and weight (1.2 kg).

Dulaglutide is an effective alternative for glycemic control and weight management in T2DM patients.

Several emerging oral agents have demonstrated promising efficacy, achieving weight loss of ≥10% in clinical trials.

Practitioners may consider these oral agents as effective options for weight management.

Incretin-based anti-obesity medications are gaining interest for their potential role in preconception care.

Healthcare providers should consider the use of incretin-based medications in preconception counseling.